| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 5e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |